New Delhi: Abbott, one of India’s leading healthcare companies recently launched the latest in Insertable Cardiac Monitor (ICM) across India, providing patients access to the world’s first and only smartphone compatible ICM. The technology is designed to help physicians remotely identify cardiac arrhythmias.
Abbott’s latest ICM is the world’s first smartphone compatible ICM to help physicians identify even the most difficult to detect cardiac arrhythmias, including atrial fibrillation (AF), in order to help guide appropriate therapy. It is designed to continuously monitor a patient’s heart rhythm and proactively transmit information via Bluetooth® wireless technology to Abbott’s dedicated mobile app for this, allowing physicians to follow their patients remotely and accurately diagnose arrhythmias that may require further treatment. The device has already received the CE Mark and USFDA approvals and is available in the EU, USA, as well as Australia.
Speaking on the importance of the device, Dr Balbir Singh, Chairman of Medanta Hospital said, “The insertable cardiac monitor is extremely useful, because as the smallest cardiac care device which can diagnose some unknown, yet dangerous heart rhythm problems, it provides early diagnosis and timely treatment to events which could be catastrophic.”
An arrhythmia is an abnormal heart rhythm that develops when disease or injury disrupts the heart’s electrical signals, causing the heart to beat erratically. As the heart begins to beat too fast or too slow, changes in blood flow can expose patients to symptoms such as palpitations, dizziness, shortness of breath or even sudden death.